Drug development in Alzheimer's disease: the contribution of PET and SPECT

Drug development in Alzheimer's disease: the contribution of PET and SPECT

Clinical trials aiming to develop disease-altering drugs for Alzheimer's disease (AD), a neurodegenerative disorder with devastating consequences, are failing at an alarming rate. Poorly defined inclusion- and outcome criteria, due to a limited amount of objective biomarkers, is one of the majo...

Full description

Saved in:
Bibliographic Details
Main Authors: Lieven Denis Herwig Declercq (Author), Rik eVandenberghe (Author), Koen eVan Laere (Author), Alfons eVerbruggen (Author), Guy eBormans (Author)
Format: Book
Published: Frontiers Media S.A., 2016-03-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items